GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUF) » Definitions » Stock Based Compensation

FSNUF (Fresenius SE KGaA) Stock Based Compensation : $0 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Fresenius SE KGaA Stock Based Compensation?

Fresenius SE KGaA's Stock Based Compensation for the three months ended in Dec. 2024 was $0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 was $0 Mil.


Fresenius SE KGaA Stock Based Compensation Historical Data

The historical data trend for Fresenius SE KGaA's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Stock Based Compensation Chart

Fresenius SE KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Fresenius SE KGaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Fresenius SE KGaA Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.


Fresenius SE KGaA Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.

Fresenius SE KGaA Headlines

From GuruFocus

Q3 2020 Fresenius SE & Co KGaA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2023 Fresenius SE & Co KGaA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2023 Fresenius SE & Co KGaA Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q1 2024 Fresenius SE & Co KGaA Earnings Call Transcript

By GuruFocus Research 05-09-2024

Fresenius SE & Co KGaA Capital Markets Day 2023 Transcript

By GuruFocus Research 02-13-2024

Q1 2021 Fresenius SE & Co KGaA Earnings Call Transcript

By GuruFocus Research 02-13-2024